Yafo Capital is an investment bank that predominately serves high-tech business. We advise on mergers and acquisitions, arrange financings, and help clients identify the best strategic partners in China. Since our inception in 2014, we have been involved in over 200 assignments on behalf of global clients covering a spectrum of high-tech businesses, from life science, TMT, Clean Tech, Agro to industrials. We also manage a venture capital fund dedicated to global technology companies and their operations in China.
GoForIsrael is one of the most prestigious business conferences in Israel. It brings together an increasing number of investors, participants， and organizations. GoForIsrael focuses on both China and emerging markets, addressing the current issues related to fund raising and establishing strategic global alliances, while keeping a strong connection with Europe and the US. In previous years, our conference has welcomed several Heads of State, including Prime Minister Ariel Sharon, Prime Minister Benjamin Netanyahu and the former French President Nicolas Sarkozy. There have been over 1,000 participants from which 300 came from overseas. Amongst them were many key decision makers and politicians.
The 16th GoForIsrael business conference was organized by Yafo Capital, Cukierman investment, and Catalyst CEL Fund. It was held on September 20th in Shanghai and 22nd in Wuhan, China 2016— the first time it took place outside Israel.
In July 2016, Yafo Capital led a delegation to visit Israeli high-tech companies. The delegation consists of 13 management team members from 4 top (out of 10) funds in China. They are Bosera Asset Management Co., Ltd (388 billion RMB under management), Penghua Fund Management (301.4 billion RMB under management), E Fund Management Co., Ltd (827 billion RMB under management), and GF Fund Management Co., Ltd (236 billion RMB under management).
We visited more than 13 companies in Israel including: CheckCap, Polypid, Evogene, Frutarom, Rewalk, MobileEye etc.
In September 2016, a delegation of 25 individuals, investors in the medical field and governmental representatives from Hubei Province, arrived for an official visit of Israel and met with the Minister of Health Yaakov Litzman. Ultimately the decision was made to open a health channel between China and Israel within the medical equipment and pharmacy market/sectors.
This delegation, containing “United Investment,” one of the largest foundations in China, and house of investments “Yafo Capital,” was led by the “Magnet Group” company. The delegation expressed its willingness to found the Israeli “Silicon Valley” in Hubei Province in China, where emphasize will be placed on the medical equipment and pharmaceutical areas.
Litzman has opened health channel between Israel and China
15 February 2017, Yafo Capital organized a product demonstration event for interested investors of “PerfAction,” an innovative cosmetic medical device company from Israel. The CEO of PerfAction, a clinical specialist, and a well-known cosmetic surgeon, who has been using the device for a long time, all gave a presentation about the device.
They also did a live demonstration on 2 volunteers we invited. Around 30 investors participated the event, 3 of them even volunteered for a skin lifting treatment after observing the effect of the device. The investors had a lively discussion with PerfAction’s. Further one to one meeting was arranged afterwards.
With the support of the Chinese and the Israeli Government of Science and Technology, we announced the established of “Israel Valley” on September 24th, 2016. To encourage the influx of oversea technology partnerships through investment, we have established a bi-annual “Israel Valley Open Competition” and major investment forum for the opportunities to meet and discuss collaborations.
On August 10th, 2016, Yafo Capital had the pleasure of inviting Isaac Blech, a leading biotechnology entrepreneur and investor, to Wuhan, China to visit Wuhan Biolake, the second key national industry base built by the Optics Valley of China. Mr. Blech shared his investment strategies and his stories of China with the audience in the Biolake Inno-Win Conference.
Mr. Blech is one of the most successful private financiers in the biotechnology industry. As an industry pioneer, he founded seven companies, all of which were subsequently brought public. These include Celgene Corporation, Genetic Systems Corporation, Icos Corporation, Nova Pharmaceuticals Corporation, and Patho Genesis Corporation.
Following the success of the 2nd eHealthcare Innovation Forum & Awards held in Shanghai onSeptember 10th and 11th, 2016 and to meet our global participants’ demand for further communications and international cooperation, the 3rd eHealthcare Innovation Forum & Awards 2016 (3rd EHIFA) was held in Wuhan, China on March 18th and 19th, 2017. We were expecting 600+ senior executives from the global healthcare fraternity to discuss how mHealth and Internet + technologies will transform China’s healthcare industry, innovations and the best practices of telemidicine and PACS, applications of medical artificial intelligence and big data tools, the best overseas investment strategies for Chinese investors and other innovative applications of advanced technologies as well as investment & international cooperation opportunities.
We have created a unique platform specifically designed to bridge the Chinese capital and global technology gap.
Our expertise allows Yafo Capital to deliver added value throughout all aspects of a transaction – opportunity identification, strategy development, deal planning, execution, negotiations, structuring, and closing.
Anchi New Energy Technology is an innovative battery R&D, manufacturing, and sales company with total investment of 3 billion yuan. Yafo Shangrao New Energy fund led the investment round of $45 million to the company in 2016 and 2017.
BT9 is an end-to-end, real-time cold chain management (CCM) solution provider headquartered in Israel. Its Xsense® CCM technology is currently used around the globe by large as well as small-medium companies.
Established in 2014, IceWorld Sports is the operator of modern modular movable ice stadium, as the brand operator of Holland Ice-World International (IWI), whom has experience of development, operation, technology support and serve of ice-sports facilities.
QualiMed is part of Q3 Medical Group, an Irish based holding company with multiple operations in Germany. Qualimed specializes in medical device implants with a primary focus on implantable mechanical devices, catheter based technologies, drug device combination products, and biodegradable and bioabsorable implants. The company has vast expertise in taking products from any point in the development process from Ideation through manufacturing and sales.
HealthWatch is a pioneer in harnessing textile technology to produce fashionable, smart-digital garments with interwoven sensors unobtrusively measuring vital signs of hospital-grade quality. In January 2017, Healthwatch announced the strategic investment of $20 million from China Yiling Pharma and its expansion to the Chinese market.
Trendlines are an innovation commercialization company. Trendlines invents, discovers, invests in, and incubates innovation-based medical and agricultural technologies. Trendlines went public in Singapore in 2016.
ZD medical Inc., founded by a number of returned overseas experts, is a hightech enterprise devoted into the R＆D, manufacturing and selling. In 2015, ZD Medical announced the acquisition of USC backed company, Varocto and expanded to PVOCT area. ZD Medical has completed two rounds of financing (amount not disclosed).
Check-Cap is a clinical stage medical diagnostics company leading the development of the first ingestible imaging capsule that utilizes low-dose X-rays for CRC screening. Founded in early 2005, Check-Cap recruited a team of world-class experts in physics, software engineering, electronics, mechanics and physiology to develop the Check-Cap multi-disciplinary imaging solution for imaging and screening of the colon. Fosun and a Chinese fund led the IPO round of $24 million.